Sign in or create an account to add this stock to your watchlist.
About Imperva (NASDAQ:IMPV)
Imperva, Inc. engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments. Its SecureSphere product also secures business-critical applications and data; and provides an accelerated route to address regulatory compliance and establishes a repeatable process for data risk management. The company's Incapsula service delivers cloud-based Website security, distributed denial of service protection, and load balancing and failover; and is designed to deploy and accessible to businesses that need to optimize the security, speed, and availability of their Websites. Its products also include ThreatRadar that provides reputation and crowdsourced security intelligence services; CounterBreach, which protects enterprise data from theft and loss due to compromised, malicious, and careless users; and Imperva Camouflage Data Masking that creates functional data for development, testing, and training by disguising sensitive information while maintaining the characteristics of the original data. In addition, the company provides ongoing product support services for hardware and software; and professional and training services. Imperva, Inc. offers its products and services to banks, retailers, insurers, technology and telecommunication companies, and hospitals; and the United States and other national, state, and local government agencies through a network of distributors and resellers. The company was founded in 2002 and is headquartered in Redwood Shores, California.
Industry, Sector and Symbol
Industry Prepackaged software
SectorComputer and Technology
Trailing P/E Ratio-169.29
Forward P/E Ratio-77.70
Sales & Book Value
Annual Sales$321.72 million
Price / Sales5.11
Cash Flow$0.0559 per share
Price / Cash847.67
Book Value$9.75 per share
Price / Book4.86
EPS (Most Recent Fiscal Year)($0.28)
Net Income$22.86 million
Return on Equity-1.63%
Return on Assets-0.97%
Imperva (NASDAQ:IMPV) Frequently Asked Questions
What is Imperva's stock symbol?
Imperva trades on the NASDAQ under the ticker symbol "IMPV."
How were Imperva's earnings last quarter?
Imperva (NASDAQ:IMPV) issued its quarterly earnings data on Thursday, April, 26th. The software maker reported $0.26 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.19 by $0.07. The software maker earned $84.24 million during the quarter, compared to analysts' expectations of $83.77 million. Imperva had a negative return on equity of 1.63% and a negative net margin of 3.00%. The firm's revenue for the quarter was up 16.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.09 earnings per share. View Imperva's Earnings History.
When is Imperva's next earnings date?
What price target have analysts set for IMPV?
17 brokerages have issued 12 month target prices for Imperva's stock. Their forecasts range from $39.00 to $61.00. On average, they expect Imperva's stock price to reach $53.6154 in the next year. View Analyst Ratings for Imperva.
What are Wall Street analysts saying about Imperva stock?
Here are some recent quotes from research analysts about Imperva stock:
- 1. BTIG Research analysts commented, "Imperva posted a strong beat on Non-GAAP EPS, a moderate beat on revenues, and weaker than expected billings, deferred revenues, operating margin and cash flows. Disruptions in the North American salesforce during the quarter seems to have created challenges in delivering the results. While Asia Pacific seems to have been off to a strong start, with Europe following, without the North America engine in full throttle, Imperva cannot get to its destination. We like management’s vision to transform into a hybrid cybersecurity leader, but until we see tangible outcomes, we are forced to remain on the sidelines. Maintain Neutral." (4/29/2018)
- 2. According to Zacks Investment Research, "Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company's SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. " (4/11/2018)
Who are some of Imperva's key competitors?
Some companies that are related to Imperva include Konami (KNMCY), Sina (SINA), Atlassian (TEAM), Paycom (PAYC), MuleSoft (MULE), LogMeIn (LOGM), National Instruments (NATI), Twilio (TWLO), New Relic (NEWR), Okta (OKTA), 2U (TWOU), RealPage (RP), Blackbaud (BLKB), Medidata Solutions (MDSO) and HubSpot (HUBS).
Who are Imperva's key executives?
Imperva's management team includes the folowing people:
- Ms. Trâm T. Phi, Sr. VP, Gen. Counsel & Corp. Sec. (Age 47)
- Mr. Christopher S. Hylen, Pres, CEO & Director (Age 57)
- Mr. Michael J. Burns, Chief Financial Officer & Treasurer (Age 52)
- Mr. Aharon Strosberg, VP of Operations
- Mr. Terry Ray, Chief Technology Officer
Has Imperva been receiving favorable news coverage?
News stories about IMPV stock have been trending positive this week, Accern Sentiment reports. Accern identifies negative and positive media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Imperva earned a daily sentiment score of 0.33 on Accern's scale. They also assigned headlines about the software maker an impact score of 48.99 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
Who are Imperva's major shareholders?
Imperva's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.52%), Eagle Asset Management Inc. (3.82%), ETF Managers Group LLC (3.31%), Millennium Management LLC (2.10%), Rothschild Asset Management Inc. (1.44%) and Northern Trust Corp (1.19%). Company insiders that own Imperva stock include Amichai Shulman, Anthony J Bettencourt, Mark E Kraynak, Michael D Mooney, Shlomo Kramer, Sunil D Nagdev and Terrence J Schmid. View Institutional Ownership Trends for Imperva.
Which major investors are selling Imperva stock?
IMPV stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., JPMorgan Chase & Co., North Run Capital LP, ETF Managers Group LLC, Millennium Management LLC, Wells Fargo & Company MN, Smith Asset Management Group LP and Point72 Asset Management L.P.. Company insiders that have sold Imperva company stock in the last year include Anthony J Bettencourt and Michael D Mooney. View Insider Buying and Selling for Imperva.
Which major investors are buying Imperva stock?
IMPV stock was purchased by a variety of institutional investors in the last quarter, including Legal & General Group Plc, Impax Asset Management LLC, Hsbc Holdings PLC, Highbridge Capital Management LLC, Segall Bryant & Hamill LLC, Broadview Advisors LLC, Roystone Capital Management LP and Prudential Financial Inc.. View Insider Buying and Selling for Imperva.
How do I buy shares of Imperva?
Shares of IMPV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Imperva's stock price today?
One share of IMPV stock can currently be purchased for approximately $47.40.
How big of a company is Imperva?
Imperva has a market capitalization of $1.64 billion and generates $321.72 million in revenue each year. The software maker earns $22.86 million in net income (profit) each year or ($0.28) on an earnings per share basis. Imperva employs 1,020 workers across the globe.
How can I contact Imperva?
Imperva's mailing address is 3400 BRIDGE PARKWAY, REDWOOD SHORES CA, 94065. The software maker can be reached via phone at 650-345-9000 or via email at [email protected]
MarketBeat Community Rating for Imperva (IMPV)MarketBeat's community ratings are surveys of what our community members think about Imperva and other stocks. Vote "Outperform" if you believe IMPV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMPV will underperform the S&P 500 over the long term. You may vote once every thirty days.
Imperva (NASDAQ:IMPV) Price Target and Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
17 Wall Street analysts have issued ratings and price targets for Imperva in the last 12 months. Their average twelve-month price target is $53.6154, suggesting that the stock has a possible upside of 13.11%. The high price target for IMPV is $61.00 and the low price target for IMPV is $39.00. There are currently 2 sell ratings, 5 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Hold."
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Hold||Buy||Buy||Buy|
|Consensus Rating Score: ||2.47||2.50||2.50||2.50|
|Ratings Breakdown: ||2 Sell Rating(s)|
5 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
|2 Sell Rating(s)|
4 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
|2 Sell Rating(s)|
4 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
|1 Sell Rating(s)|
6 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$53.6154||$53.2308||$53.1538||$52.5833|
|Price Target Upside: ||13.11% upside||21.12% upside||14.19% upside||29.52% upside|
Imperva (NASDAQ:IMPV) Consensus Price Target History
Imperva (NASDAQ:IMPV) Analyst Ratings History
(Data available from 5/20/2016 forward)
Imperva (NASDAQ:IMPV) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Imperva (NASDAQ IMPV) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.10%
Imperva (NASDAQ IMPV) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|2/20/2018||Anthony J Bettencourt||Director||Sell||66,037||$46.98||$3,102,418.26||66,037|| |
|2/20/2018||Michael D Mooney||CRO||Sell||24,454||$47.18||$1,153,739.72||24,454|| |
|8/24/2017||Anthony J Bettencourt||Director||Sell||99,598||$43.59||$4,341,476.82||99,598|| |
|5/16/2017||Sunil D Nagdev||SVP||Sell||4,857||$49.00||$237,993.00||16,290|| |
|5/15/2017||Amichai Shulman||Insider||Sell||3,089||$48.70||$150,434.30||100,151|| |
|5/10/2017||Michael D Mooney||CRO||Sell||52,356||$47.51||$2,487,433.56||52,356|| |
|4/17/2017||Amichai Shulman||Insider||Sell||3,085||$41.97||$129,477.45||99,151|| |
|3/15/2017||Amichai Shulman||Insider||Sell||3,085||$41.85||$129,107.25||99,151|| |
|2/28/2017||Mark E Kraynak||SVP||Sell||45,314||$41.63||$1,886,421.82||10,064|| |
|2/21/2017||Anthony J Bettencourt||Chairman||Sell||84,863||$45.55||$3,865,509.65||84,863|| |
|2/21/2017||Terrence J Schmid||CFO||Sell||4,500||$45.53||$204,885.00||432|| |
|2/16/2017||Mark E Kraynak||SVP||Sell||1,731||$46.10||$79,799.10||3,858|| |
|2/15/2017||Amichai Shulman||Insider||Sell||3,085||$45.91||$141,632.35||95,713|| |
|1/17/2017||Amichai Shulman||CTO||Sell||3,085||$40.60||$125,251.00|| |
|12/21/2016||Amichai Shulman||Insider||Sell||3,085||$40.00||$123,400.00||91,830|| |
|11/16/2016||Mark E Kraynak||SVP||Sell||3,332||$40.16||$133,813.12||448|| |
|11/15/2016||Amichai Shulman||Insider||Sell||3,085||$40.10||$123,708.50||92,000|| |
|10/17/2016||Amichai Shulman||Insider||Sell||3,085||$48.57||$149,838.45||91,062|| |
|10/3/2016||Amichai Shulman||Insider||Sell||938||$53.27||$49,967.26||95,085|| |
|9/23/2016||Amichai Shulman||Insider||Sell||937||$51.00||$47,787.00||95,084|| |
|9/23/2016||Mark E. Kraynak||SVP||Sell||5,582||$51.00||$284,682.00|| |
|9/15/2016||Amichai Shulman||Insider||Sell||3,085||$44.30||$136,665.50||94,147|| |
|8/16/2016||Mark E Kraynak||SVP||Sell||2,614||$47.73||$124,766.22||3,552|| |
|8/15/2016||Amichai Shulman||Insider||Sell||3,085||$46.87||$144,593.95||94,317|| |
|7/27/2016||Amichai Shulman||Insider||Sell||3,085||$46.28||$142,773.80||93,380|| |
|7/26/2016||Mark E Kraynak||SVP||Sell||2,967||$46.15||$136,927.05||2,968|| |
|6/23/2016||Shlomo Kramer||Major Shareholder||Sell||75,000||$45.12||$3,384,000.00||1,304,521|| |
|6/20/2016||Shlomo Kramer||Major Shareholder||Sell||75,000||$40.24||$3,018,000.00||1,304,521|| |
|5/31/2016||Terrence J Schmid||CFO||Sell||5,000||$37.66||$188,300.00||335|| |
|5/25/2016||Anthony J Bettencourt||CEO||Sell||50,000||$36.15||$1,807,500.00||52,938|| |
|5/19/2016||Shlomo Kramer||Major Shareholder||Sell||50,000||$34.20||$1,710,000.00||1,304,521|| |
|5/17/2016||Shlomo Kramer||Major Shareholder||Sell||75,000||$33.95||$2,546,250.00||1,304,521|| |
|5/16/2016||Terrence J Schmid||CFO||Sell||7,000||$33.99||$237,930.00||8,053|| |
|5/12/2016||Shlomo Kramer||Major Shareholder||Sell||75,000||$34.16||$2,562,000.00||1,304,521|| |
|3/31/2016||Mark E. Kraynak||SVP||Sell||2,758||$50.00||$137,900.00|| |
|3/1/2016||Amichai Shulman||CTO||Sell||3,000||$45.25||$135,750.00||89,527|| |
|2/24/2016||Terrence J Schmid||CFO||Sell||6,500||$41.82||$271,830.00||7,468|| |
|2/17/2016||Mark E Kraynak||SVP||Sell||2,758||$40.04||$110,430.32||2,758|| |
|2/8/2016||Albert A Pimentel||Director||Buy||5,000||$38.93||$194,650.00||4,475|| |
|2/8/2016||Amichai Shulman||CTO||Sell||4,150||$38.12||$158,198.00||82,590|| |
|2/1/2016||Amichai Shulman||CTO||Sell||3,000||$50.49||$151,470.00||86,740|| |
|1/4/2016||Amichai Shulman||CTO||Sell||5,812||$60.36||$350,812.32||86,740|| |
|12/1/2015||Amichai Shulman||CTO||Sell||3,000||$74.22||$222,660.00||86,740|| |
|11/19/2015||Mark E. Kraynak||insider||Sell||10,000||$75.00||$750,000.00|| |
|11/19/2015||Tram T. Phi||VP||Sell||1,244||$73.26||$91,135.44||5,975|| |
|11/16/2015||Anthony J. Bettencourt||CEO||Sell||50,000||$69.33||$3,466,500.00||8,489|| |
|11/16/2015||Mark E. Kraynak||insider||Sell||3,789||$68.73||$260,417.97|| |
|11/12/2015||Shlomo Kramer||Major Shareholder||Sell||100,000||$71.65||$7,165,000.00||1,259,521|| |
|11/6/2015||Shlomo Kramer||Major Shareholder||Sell||50,000||$72.14||$3,607,000.00||1,259,521|| |
|11/4/2015||Shlomo Kramer||Major Shareholder||Sell||25,000||$72.05||$1,801,250.00||1,259,521|| |
|11/4/2015||Terrence J. Schmid||CFO||Sell||938||$71.14||$66,729.32|| |
|11/3/2015||Shlomo Kramer||Major Shareholder||Sell||25,000||$72.55||$1,813,750.00||1,259,521|| |
|10/1/2015||Amichai Shulman||CTO||Sell||2,813||$65.00||$182,845.00||84,802|| |
|8/31/2015||Terrence J. Schmid||CFO||Sell||1,595||$61.56||$98,188.20|| |
|8/17/2015||Mark E Kraynak||Insider||Sell||1,520||$71.42||$108,558.40|| |
|7/23/2015||Amichai Shulman||CTO||Sell||9,000||$70.00||$630,000.00|| |
|5/11/2015||Amichai Shulman||CTO||Sell||10,313||$51.09||$526,891.17|| |
|5/11/2015||Mark E Kraynak||Insider||Sell||4,000||$55.00||$220,000.00|| |
|4/20/2015||Mark E Kraynak||Insider||Sell||3,000||$47.53||$142,590.00|| |
|1/20/2015||Mark E Kraynak||Insider||Sell||3,000||$44.60||$133,800.00|| |
|1/8/2015||Amichai Shulman||CTO||Sell||1,875||$50.00||$93,750.00|| |
|12/16/2014||Amichai Shulman||CTO||Sell||9,492||$50.00||$474,600.00|| |
|12/15/2014||Amichai Shulman||CTO||Sell||11,133||$50.00||$556,650.00|| |
|12/1/2014||Amichai Shulman||CTO||Sell||5,000||$42.44||$212,200.00|| |
|11/28/2014||Yaniv Shaya||VP||Sell||2,512||$44.00||$110,528.00|| |
|11/20/2014||Mark E Kraynak||Insider||Sell||6,140||$42.00||$257,880.00|| |
|11/14/2014||Yaniv Shaya||VP||Sell||20,938||$44.52||$932,159.76|| |
|11/13/2014||Mark E Kraynak||Insider||Sell||2,000||$45.00||$90,000.00|| |
|11/11/2014||Tram T Phi||VP||Sell||10,076||$43.50||$438,306.00|| |
|11/4/2014||Terrence J Schmid||CFO||Sell||20,000||$40.73||$814,600.00|| |
|11/3/2014||Amichai Shulman||CTO||Sell||5,000||$41.09||$205,450.00|| |
|10/31/2014||Amichai Shulman||CTO||Sell||7,500||$36.56||$274,200.00|| |
|10/31/2014||Mark E Kraynak||Insider||Sell||2,000||$36.56||$73,120.00|| |
|10/6/2014||Amichai Shulman||CTO||Sell||2,500||$30.00||$75,000.00|| |
|9/2/2014||Amichai Shulman||CTO||Sell||5,000||$30.00||$150,000.00|| |
|8/21/2014||Terrence J Schmid||CFO||Sell||15,000||$29.07||$436,050.00|| |
|5/23/2014||Ralph Pisani||VP||Sell||8,613||$21.31||$183,543.03|| |
|5/21/2014||Terrence Schmid||CFO||Sell||15,000||$21.26||$318,900.00||2,853|| |
|4/7/2014||Shlomo Kramer||CEO||Sell||60,000||$50.53||$3,031,800.00||1,229,521|| |
|4/2/2014||Shlomo Kramer||CEO||Sell||40,000||$55.67||$2,226,800.00||1,229,521|| |
|1/8/2014||Shlomo Kramer||CEO||Sell||20,000||$50.10||$1,002,000.00||1,219,521|| |
|1/7/2014||Shlomo Kramer||CEO||Sell||40,000||$49.99||$1,999,600.00||1,219,521|| |
|1/3/2014||Shlomo Kramer||CEO||Sell||40,000||$48.31||$1,932,400.00||1,219,521|| |
|1/2/2014||Amichai Shulman||CTO||Sell||22,875||$47.68||$1,090,680.00||10,000|| |
|12/17/2013||Amichai Shulman||CTO||Sell||10,090||$45.00||$454,050.00||10,000|| |
|12/2/2013||Amichai Shulman||CTO||Sell||12,410||$44.13||$547,653.30||10,000|| |
|11/26/2013||Yaniv Shaya||VP||Sell||5,243||$43.92||$230,272.56||5,000|| |
|11/21/2013||Jason Forget||SVP||Sell||8,558||$38.98||$333,590.84|| |
|11/21/2013||Terrence Schmid||CFO||Sell||11,100||$40.26||$446,886.00|| |
|11/21/2013||Tram Phi||VP||Sell||6,646||$39.50||$262,517.00|| |
|11/19/2013||Mark Kraynak||VP||Sell||3,190||$37.80||$120,582.00||15,000|| |
|8/29/2013||Yaniv Shaya||VP||Sell||4,375||$48.00||$210,000.00|| |
|8/26/2013||Jason Forget||SVP||Sell||2,500||$47.50||$118,750.00|| |
|8/26/2013||Yaniv Shaya||VP||Sell||5,000||$47.71||$238,550.00|| |
|8/23/2013||Terrence Schmid||CFO||Sell||2,539||$47.20||$119,840.80|| |
|8/21/2013||Jason Forget||SVP||Sell||2,500||$47.00||$117,500.00|| |
|8/20/2013||Terrence Schmid||CFO||Sell||10,461||$47.03||$491,980.83|| |
|8/16/2013||Jason Forget||SVP||Sell||2,062||$47.00||$96,914.00|| |
|8/14/2013||Tram Phi||VP||Sell||5,000||$46.00||$230,000.00|| |
|8/13/2013||Jason Forget||SVP||Sell||2,000||$45.01||$90,020.00|| |
|8/13/2013||Mark Kraynak||VP||Sell||10,000||$44.41||$444,100.00||15,000|| |
|8/5/2013||Amichai Shulman||CTO||Sell||1,086||$52.58||$57,101.88|| |
|8/2/2013||Amichai Shulman||CTO||Sell||46,140||$51.87||$2,393,281.80|| |
|7/3/2013||Amichai Shulman||CTO||Sell||3,222||$45.21||$145,666.62|| |
|7/1/2013||Amichai Shulman||CTO||Sell||16,778||$44.94||$754,003.32|| |
|6/3/2013||Amichai Shulman||CTO||Sell||20,000||$39.49||$789,800.00|| |
|5/30/2013||Amichai Shulman||CTO||Sell||10,000||$39.93||$399,300.00|| |
|5/30/2013||Yaniv Shaya||VP||Sell||4,375||$40.40||$176,750.00|| |
|5/29/2013||Amichai Shulman||CTO||Sell||20,000||$39.96||$799,200.00|| |
|5/28/2013||Tram T Phi||VP||Sell||5,000||$40.25||$201,250.00|| |
|5/24/2013||Yaniv Shaya||VP||Sell||2,250||$40.00||$90,000.00|| |
|5/14/2013||Yaniv Shaya||VP||Sell||10,000||$39.00||$390,000.00|| |
|5/13/2013||Albert A Pimentel||Director||Sell||10,000||$37.93||$379,300.00|| |
|5/13/2013||Ralph Pisani||VP||Sell||5,000||$38.46||$192,300.00|| |
|5/13/2013||Terrence J Schmid||CFO||Sell||13,000||$37.75||$490,750.00|| |
|5/8/2013||Jason Forget||SVP||Sell||4,063||$37.31||$151,590.53|| |
|3/26/2013||Amichai Shulman||CTO||Sell||20,000||$38.30||$766,000.00|| |
|2/26/2013||Amichai Shulman||CTO||Sell||20,000||$36.05||$721,000.00|| |
|12/28/2012||Amichai Shulman||CTO||Sell||10,000||$31.01||$310,100.00|| |
|12/27/2012||Amichai Shulman||CTO||Sell||20,000||$30.98||$619,600.00|| |
|12/5/2012||Michael Boodaei||Director||Sell||30,000||$31.48||$944,400.00|| |
|11/27/2012||Amichai Shulman||CTO||Sell||20,000||$29.06||$581,200.00|| |
|11/7/2012||James R Tolonen||Director||Buy||5,000||$31.17||$155,850.00|| |
|11/1/2012||Amichai Shulman||CTO||Sell||20,000||$31.71||$634,200.00|| |
|10/4/2012||Michael Boodaei||Director||Sell||30,000||$34.03||$1,020,900.00|| |
|9/5/2012||Michael Boodaei||Director||Sell||20,000||$30.35||$607,000.00|| |
Imperva (NASDAQ IMPV) News Headlines
Imperva (NASDAQ:IMPV) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Imperva (NASDAQ:IMPV) Income Statement, Balance Sheet and Cash Flow Statement
Imperva (NASDAQ IMPV) Stock Chart for Sunday, May, 20, 2018